Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Skin reactions from cancer treatments might predict how well the treatments work.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Tadalafil and Finasteride may help treat aggressive melanoma.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Chemotherapy and certain hair care practices can cause severe hair matting.

Compound 7p shows strong potential as an anticancer agent.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.